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Abstract
Background: Human papilloma virus (HPV) infection is one of the most common sexually trans-
mitted diseases that affects men like women and infected cutaneous and mucosal squamous epitheli-
um. The aim of the present study was to determine the prevalence of HPV in the semen of oligo-
spermic, azoospermic and normal patients.
Methods: From June 2012 to June 2013, a total of 90 individuals were enrolled in this cross sec-
tional comparative study. The participants were classified into three groups (oligospermia, azoos-
prmia and normal). This classification was based on a new WHO reference values for human semen
characteristics published on 2010. After extraction of DNA from specimens L1 gene of HPV was
amplified by nested polymerase chain reaction (Nested-PCR) and the PCR products of positive spec-
imens were genotyped using INNO-LiPA HPV Genotyping Extra assay.
Results: Among 50 confirmed oligospermic male, 15 were HPV DNA positive (30%). In
azoospemic group we had 8 HPV DNA positive (40%) and in normal group just 3 of 20(15%) sam-
ples were positive. Statistical assessment was done with SPSS v.15. Chi-square test showed no sig-
nificant relationship between 3 groups results. Based on independent samples t-test, we found statis-
tical significant relationship for sperm count (p<0.05) and sperm motility (slow) (p<0.05) in oligo-
spermic group positive samples compared with negative. In the present study, 13 HPV genotypes
were detected among positive samples. HPV genotypes 16, 45 in the high risk group and 6,11,42 in
the low risk group were more frequent than the others.
Conclusion: The current study shows that HPV infection can affect on sperm count and motility
and decrease count of sperm cell and decrease motility capability of these cells.
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Introduction
Human papilloma virus (HPV), A group
of small non-enveloped, double-stranded
DNA viruses and one of the most common
sexually transmitted agent, that implicate
males and females from various regions
(1).These viruses have worldwide distribu-
tion with over 120 known genotype and can
be identified based on their tropism, one
that infects skin and cutaneous surfaces (μ,
β, γ, ν subtypes) and one that infects inter-
nal, moist-squamous mucous membranes
(α) (2). Pubic area, oral cavity, perianal and
genital tract are regions that can be infected
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(3,4), These viruses can be transmitted
through skin contact or any other surface
contact, it may be horizontal (by genital-
genital, manual-genital, or oral-genital con-
tact) or vertical (from mother to fetus)
(2,5).
More than 90% of all cancers of the cer-
vix caused by high-risk HPVs (oncogenic:
16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58,
59, 68, 73, 82; probably carcinogenic: 26,
53, 66) (6) (HPV-16 more than 50% and
HPV-18 about 20%); the low-risk HPVs,
such as 6,11,40, 42, 43, 44, 54, 61, 70, 72,
81, are generally associated with genital
warts; the cutaneous HPV-2 causes com-
mon warts, especially in children (7,8).
HPV infection is very common both among
men and women. Around 75% of sexually
active people will have an HPV infection at
some point of life (8-12). Most HPV infec-
tions among males are benign (e.g., genital
warts) and often infrequent and assess-
ments shows that have no tendency for ma-
lignancy too (8,13,14). Several new studies
shows viral infections of genital tract may
play important role for male infertility (15),
deterioration of spermatogenesis (15), can
affect on sperm quality and parameters (16)
and impairment of sperm function such as
count or motility (17-19)
HPV DNA and RNA have been well
documented in anal region, perineal area,
scrotum, glans, penile shaft, urethra and
reproductive system (testis, epididymis, and
ducts deferens) (16,18, 20-22). Several
studies have documented the presence of
HPV in the semen with different prevalence
(12,23).
Hence, the aim of the current study was to
investigate the status of HPV infection in
Iranian males by detection of HPV in the
semen of oligospermic, azoospermic and
normal patients that confirmed with semen
analysis, and assessment the effects of HPV
infection on semen parameters and charac-
teristics of HPV genotype distribution to
promote further discussion about the effects
of HPV infection on male infertility.
Methods
Patients
The study protocol was approved by the
local ethics committee. From June 2012
until June 2013 we accumulate ejaculated
samples among males aged 26-55 years
(median 39 years) attending to fertility clin-
ics.
By Computer-Aided semen Analysis
(CASA) system and based on new WHO
reference values for human semen charac-
teristics published on 2010 (24) we consid-
ered 3 study groups including oligospermic
male group with 50 samples, azoospermic
male group with 20 samples and normal
male group with 20 samples.
Samples
Semen samples were collected in a pri-
vate room and maintained at room tempera-
ture until complete seminal liquefaction
(25). After liquefaction, semen parameters
contain of sample volume, sperm concen-
tration, sperm count, motility, and progres-
sivity were determined using Computer-
Aided semen Analysis(CASA) system (26).
Approximately 1 mL of each specimen was
taken for HPV DNA extraction. All ex-
tracted samples were stored in -20˚C until
use (27).
DNA Extraction
After collection each semen sample was
centrifuged at 2,500 rpm for 10 minutes.
The supernatant was removed and the pellet
was transferred to an Eppendorf tube. DNA
extraction was done using a high pure viral
Table 1. MY09/11, GP05/06 primer sequence
MY09/11 forward primer (First round) MY09/11 reverse primer
5'-CGTCCMARRGGAWACTGATC-3' 5'-GCMCAGGGWCATAAYAATGG-3'
GP05 forward primer (Second round) GP06 reverse primer
5'-TTTGTTACTGTGGTAGATAC-3' 5'-ACTAAATGTCAAATAAAAAG-3'
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nucleic acid kit (Roche Diagnostics GmbH,
Mannheim, Germany) according to the
manufacturer’s instructions (Table 1).
Genotyping
The INNO-LiPA HPV Genotyping Extra
assay (Innogenetics, Gent, Belgium) utiliz-
es a biotinylated consensus primers
(SPF10) to amplify a 65-bp region within
the L1 ORF of multiple HPV types and
based on reverse line blot hybridization. A
poly(dT) tail was enzymatically added to
the 3′ end of each of 25 oligonucleotides
specific for 25 different types, namely,
types 6, 11, 16, 18, 31, 33, 34, 35, 39, 40,
42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59,
66, 68/73, 70, and 74. Amplification of the
human major histocompatibility complex,
class II gene was used to monitor the sam-
ple quality and the efficiency of the DNA
extraction equal volumes (10 μl each) of
the biotinylated PCR products and denatur-
ation solution (400 mmol/liter NaOH, 10
mmol/liter EDTA) were mixed in test
troughs and incubated at room temperature
for 5 min, after which 1 ml of prewarmed
(37°C) hybridization solution (3× SSC [1×
SSC is 0.15 mol/liter NaCl plus 0.015
mol/liter sodium citrate], 0.1% sodium do-
decyl sulfate) was added, followed by the
addition of one strip per trough. Hybridiza-
tion was performed for 1 h at 50 ± 0.5°C in
a closed water bath with back-and-forth
shaking. The strips were then washed twice
with 1 ml of washing solution (3× SSC,
0.1% sodium dodecyl sulfate) at room tem-
perature for 20 s and once at 50°C for 30
min. Following this stringent washing,
strips were rinsed twice with 1 ml of a
standard rinse solution. Strips were then
incubated on a rotating platform with an
alkaline phosphatase-labeled streptavidin
conjugate diluted in a standard conjugate
solution, at 20 to 25°C for 30 min, after
which strips were washed twice with 1 ml
of rinse solution and once with standard
substrate buffer; color development was
initiated by the addition of 5-bromo-4-
chloro-3-indolylphosphate and nitroblue
tetrazolium to 1 ml of substrate buffer. Af-
ter 30 min of incubation at room tempera-
ture, the color reaction was stopped by as-
piration of the substrate buffer and addition
of distilled water. After drying, the strips
were visually interpreted using a grid.
Results
Nested-PCR were done for 90 DNA ex-
tracted semen samples as described above
and after that with 2% agarose gel electro-
phoresis, we consider 151bp region as posi-
tive (Fig. 1).
Ninety men attended to this study, the av-
erage age of them was 39.70 years (range:
22–55 years). By CASA and based on
WHO guidelines, we classified these sub-
jects to 3 groups. Of 50 subjects in the oli-
gospermic group, 15 ones (30%) were
Fig.1. left to right: Ladder (100bp), positive control, negative control, between
100bp and 200bp region show as positive, another sample is negative.
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HPV-positive, in azoospermic group with
20 subjects, 8 subjects (40%) were positive,
and in normal group 3 (15%) of 20 subjects
were positive (Table 2).
Chi-square test showed that the infection
rate in the 3 groups was not significant be-
tween groups (p>0.05). Statistical analysis
of semen parameters were done by inde-
pendent sample t-test. In Oligospermic
group, subsequently sperm count (p<0.001)
and slow progressive motility (p=0.005)
showed statistical significant relation be-
tween HPV positive and negative samples
(p<0.05) (Table 3).
As well, other semen parameters were an-
alyzed and showed no statistical significant
relation (Table 3). In azoospermic group
(no spermatozoa can be detected in semen
sample) (32,33) we had not semen parame-
ters (Table 3). No significant difference of
sperm parameters was found between sub-
jects of normal group (Table 2).
Analysis of HPV Genotyping
Of 28 genotypes fixed on INNO-LiPA
HPV genotyping extra assay we found 13
genotypes from 26 nested-PCR positive
samples. HPV genotypes 16,18,45,52 in
high risk group and 6,11,34,40,42,43,
44,54,66  in low risk group were detected.
In oligospermic group HPV genotypes
6,11,16,34,40,42,43,44,45,52,54,66; in
azoospermic group HPV genotypes 6,11,
16,18,34,40,42,45 and in normal group just
6, 11,43 were found. HPV genotypes 6, 11,
42 among 26 HPV DNA positive subjects
were more frequent than others (Table 4).
Table 2. The frequency distribution of Semen parameter
Oligospermia Azoospermia Normal Total
Age (years) 26-55 29-55 22-52 22-55
Total
Negative
Positive
50 (55.5)
35 (54.7)
15 (57.7)
20 (22.2)
12 (18.7)
8 (30.7)
20 (22.2)
17 (26.6)
3 (11.5)
90
64
26
Table 3. Descriptive statistics of Nested-PCR Result and Semen parameter
Oligospermia
(Mean±SD)
p Azoospermia Normal
(Mean±SD)
p
Count (Million/ml) P
N
7.833±3.682 <0.001 0 88.000±29.484 0.766
13.745±4.463 <0.001 0 98.647±13.986 0.769
Quick progressive
Motility (%)
P
N
2.200±3.569 0.057 0 23.666±7.310 0.355
5.000±6.512 0.125 0 14.941±1.491 0.065
Slow progressive
Motility (%)
P 29.133±8.253 0.005 0 34.666±2.728 0.337
N 21.000±9.616 0.006 0 38.117±1.322 0.319
Non progressive
Motile (%)
P
N
9.133±5.514 0.665 0 8.000±0.154 0.095
8.400±5.180 0.655 0 11.000±0.813 0.156
Normal
Morphology (%)
P
N
6.000±2.618 0.782 0 17.333±5.333 0.831
6.228±2.734 0.785 0 18.647±1.191 0.710
Table 4. HPV Genotyping analysis
HPV genotype Oligospermia Azoospermia Normal Total
Highrisk
16 1 1 0 2
18 0 1 0 1
45
52
1
1
1
0
0
0
2
1
Low risk
6 2 1 1 4
11
34
40
42
43
44
54
66
1
1
1
3
0
1
2
1
1
1
1
1
0
0
0
0
1
0
0
0
1
0
0
0
3
2
2
4
1
1
2
1
Total 15 8 3 26
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Discussion
The real prevalence of subclinical HPV
infection in the general population and es-
pecially among men is unknown yet, be-
cause of the lack of a ‘gold standard’ diag-
nostic test for detecting subclinical HPV.
The prevalence vary depends on the specif-
ic definition used, the characteristics of the
populations screened, and the frequency
and types of diagnostic tests employed.
Several epidemiologic studies about HPV
infection in females have been reported, but
data on HPV prevalence in male, especially
in Iranian males is rare. In this study, 90
semen samples were tested for HPV DNA
with nested-PCR that 28.88% of them had
HPV infection. These samples categorized
by CASA in three groups. By analyzing
semen parameters and comparing with
HPV positive result, we found that HPV
infection can decrease the semen quality,
particularly sperm count and sperm motili-
ty. Our research data suggest that HPV in-
fected semen sample have lower sperm
count and higher slow progressive motility
sperm rate, which shows that HPV infec-
tion affects male fertility; therefore, HPV
infection can cause infertility. Some studies
show that HPV infection diminishes sperm
vitality (2) and HPV virus may act on with
the same mechanism to impact sperm capa-
bility like other viruses that can do it.
Rintala et al found this virus in Vasa Def-
erens and seminal plasma sample (34). This
virus localizes at the equatorial region of
sperm head through interaction between the
HPV capsid protein L1 and syndecan-1(2)
and can decrease function of the acrosome,
thus affecting the fusion of gametes. (3).
HPV were found in testicular biopsies of
azoospermic men and when present inside
sperm cells, they may be related to im-
paired sperm motility and azoospermia
(16). Sperm motility parameters seem to be
affected by the presence of HPV in the
sperm cells, and also the incidence of azoo-
spermia may be associated with HPV infec-
tion (35). In the present study HPV-positive
subjects were stable in semen parameters
expect of count and motility; that they have
statistical significant relationship with HPV
infection in oligospermic subjects, this pa-
rameter is important and directly can lead
to infertility. In oligospermic group 30%
and in azoospermic group 40% were HPV
positive that compared with normal group
with 15% had more frequency in these
groups. The most common HPV genotypes
among the 90 subjects were HPV- geno-
types 6, 11, 42. Further studies needs to
increase numbers of samples and time to
follow-up subjects and their partners.
Conclusion
This study indicated the prevalence of
HPV infection and distribution of HPV
genotypes among Iranian men. HPV infec-
tion may play important role in decrease of
sperm cell efficiency, and frequently asso-
ciated with reduced sperm motility and
count and may be an important agent for
oligospermia and azoospermia; that subse-
quently can lead to decreased male fertility
or even infertility.
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